Children's Health | Diseases of the Respiratory Systems, Phase III
Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps
Volunteers
Health Professionals
What is the purpose of this trial?
To evaluate the efficacy of intranasal administration of OPN-375 186 μg twice a day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion
- Trial withOptinose
- Ages12 years - 17 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
- Last Updated10/23/2024
- Study HIC#2000023985